Literature DB >> 24914395

Ehealth monitoring in irritable bowel syndrome patients treated with low fermentable oligo-, di-, mono-saccharides and polyols diet.

Natalia Pedersen1, Zsuzsanna Vegh1, Johan Burisch1, Lisbeth Jensen1, Dorit Vedel Ankersen1, Maria Felding1, Nynne Nyboe Andersen1, Pia Munkholm1.   

Abstract

In the present study we report on changes in irritable bowel syndrome-severity scoring system (IBS-SSS) and irritable bowel syndrome-quality of life (IBS-QoL) in 19 IBS patients, aged 18 to 74 years (F/M: 14/5), during 12 wk registering their symptoms on the web-application (www.ibs.constant-care.dk). During a control period of the first 6-wk patients were asked to register their IBS-SSS and IBS-QoL on the web-application weekly without receiving any intervention. Thereafter, low fermentable oligo-, di-, mono-saccharides and polyols (FODMAP) diet (LFD) was introduced for the next 6 wk while continuing the registration. Though a small sample size a significant improvement in disease activity (IBS-SSS) was observed during both the control period, median: 278 (range: 122-377), P = 0.02, and subsequently during the LFD period, median: 151 (range: 29-334), P < 0.01. The IBS-QoL solely changed significantly during the LFD period, median: 67 (37-120), P < 0.01. The significant reduction in disease activity during the control period shows a positive effect of the web-application on IBS symptoms when presented as a "traffic light". However adding the diet reduced IBS-SSS to < 150, inactive to mild symptoms. In the future results from larger scale trials are awaited.

Entities:  

Keywords:  Disease activity; Disease-specific quality of life; Irritable bowel syndrome; Low fermentable oligo-, di-, mono-saccharides and polyols diet; Self-management

Mesh:

Substances:

Year:  2014        PMID: 24914395      PMCID: PMC4047359          DOI: 10.3748/wjg.v20.i21.6680

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  17 in total

Review 1.  The functional gastrointestinal disorders and the Rome III process.

Authors:  Douglas A Drossman
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

2.  Developing a Web-based education and counseling program for heart failure patients.

Authors:  Lorraine S Evangelista; Anna Strömberg; Cheryl Westlake; Alvina Ter-Galstanyan; Nancy Anderson; Kathleen Dracup
Journal:  Prog Cardiovasc Nurs       Date:  2006

3.  The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress.

Authors:  C Y Francis; J Morris; P J Whorwell
Journal:  Aliment Pharmacol Ther       Date:  1997-04       Impact factor: 8.171

4.  Epidemiological aspects of irritable bowel syndrome in Europe and North America.

Authors:  S A Müller-Lissner; S Bollani; R J Brummer; G Coremans; M Dapoigny; J K Marshall; J W Muris; A Oberndorff-Klein Wolthuis; F Pace; L Rodrigo; R Stockbrügger; M H Vatn
Journal:  Digestion       Date:  2001       Impact factor: 3.216

5.  Quality of life in persons with irritable bowel syndrome: development and validation of a new measure.

Authors:  D L Patrick; D A Drossman; I O Frederick; J DiCesare; K L Puder
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

6.  Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management.

Authors:  Susan J Shepherd; Peter R Gibson
Journal:  J Am Diet Assoc       Date:  2006-10

7.  Internet-based monitoring of asthma: a long-term, randomized clinical study of 300 asthmatic subjects.

Authors:  Linda M Rasmussen; Klaus Phanareth; Hendrik Nolte; Vibeke Backer
Journal:  J Allergy Clin Immunol       Date:  2005-06       Impact factor: 10.793

8.  Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence.

Authors:  Susan J Shepherd; Francis C Parker; Jane G Muir; Peter R Gibson
Journal:  Clin Gastroenterol Hepatol       Date:  2008-05-05       Impact factor: 11.382

9.  The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study.

Authors:  R H de Roest; B R Dobbs; B A Chapman; B Batman; L A O'Brien; J A Leeper; C R Hebblethwaite; R B Gearry
Journal:  Int J Clin Pract       Date:  2013-05-23       Impact factor: 2.503

Review 10.  Disaccharide digestion: clinical and molecular aspects.

Authors:  Claudia C Robayo-Torres; Roberto Quezada-Calvillo; Buford L Nichols
Journal:  Clin Gastroenterol Hepatol       Date:  2006-03       Impact factor: 11.382

View more
  20 in total

Review 1.  Telemedicine and Mobile Health Technology Are Effective in the Management of Digestive Diseases: A Systematic Review.

Authors:  Brian C Helsel; Joel E Williams; Kristen Lawson; Jessica Liang; Jonathan Markowitz
Journal:  Dig Dis Sci       Date:  2018-04-16       Impact factor: 3.199

Review 2.  Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis.

Authors:  Abigail Marsh; Enid M Eslick; Guy D Eslick
Journal:  Eur J Nutr       Date:  2015-05-17       Impact factor: 5.614

3.  Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome.

Authors:  Natalia Pedersen; Nynne Nyboe Andersen; Zsuzsanna Végh; Lisbeth Jensen; Dorit Vedel Ankersen; Maria Felding; Mette Hestetun Simonsen; Johan Burisch; Pia Munkholm
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

Review 4.  Restriction of FODMAP in the management of bloating in irritable bowel syndrome.

Authors:  Wei Mon Wong
Journal:  Singapore Med J       Date:  2016-09       Impact factor: 1.858

5.  Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet.

Authors:  Louise Maagaard; Dorit V Ankersen; Zsuzsanna Végh; Johan Burisch; Lisbeth Jensen; Natalia Pedersen; Pia Munkholm
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

Review 6.  Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date.

Authors:  Wathsala S Nanayakkara; Paula Ml Skidmore; Leigh O'Brien; Tim J Wilkinson; Richard B Gearry
Journal:  Clin Exp Gastroenterol       Date:  2016-06-17

7.  The Low FODMAP Diet and Its Application in East and Southeast Asia.

Authors:  Marina Iacovou; Victoria Tan; Jane G Muir; Peter R Gibson
Journal:  J Neurogastroenterol Motil       Date:  2015-10-01       Impact factor: 4.924

8.  Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD.

Authors:  C Casén; H C Vebø; M Sekelja; F T Hegge; M K Karlsson; E Ciemniejewska; S Dzankovic; C Frøyland; R Nestestog; L Engstrand; P Munkholm; O H Nielsen; G Rogler; M Simrén; L Öhman; M H Vatn; K Rudi
Journal:  Aliment Pharmacol Ther       Date:  2015-05-14       Impact factor: 8.171

9.  Low-FODMAP formula improves diarrhea and nutritional status in hospitalized patients receiving enteral nutrition: a randomized, multicenter, double-blind clinical trial.

Authors:  So Ra Yoon; Jong Hwa Lee; Jae Hyang Lee; Ga Yoon Na; Kyun-Hee Lee; Yoon-Bok Lee; Gu-Hun Jung; Oh Yoen Kim
Journal:  Nutr J       Date:  2015-11-03       Impact factor: 3.271

10.  Fructose Malabsorption in Systemic Sclerosis.

Authors:  Isabelle Marie; Anne-Marie Leroi; Guillaume Gourcerol; Hervé Levesque; Jean-François Ménard; Philippe Ducrotte
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.